France Diabetes Care Devices Market Analysis and Forecasts to 2015 --- Aarkstore Enterprise

 updated 2008 data.
SummaryAnalysis of the leading companies and competitive
Medical device report: "France Diabetes Carelandscape including 2008 company market share
Devices Market Analysis and Forecasts to 2015"analysis.
report provides key data, information and analysisAnalysis of key diabetes care pipeline products,
on the France diabetes care devices market. Thenew technologies and clinical trials.
report provides market landscape, competitiveInsight into the key mergers and acquisitions
landscape and market trends information on two(M&As), partnerships, venture capital and
market categories - glucose monitoring and insulinprivate equity investments.
delivery. The report provides comprehensiveQualitative analysis of market drivers, market
information on the key trends affecting theselimiters regulatory issues and future outlook.
categories, and key analytical insight on theReasons to buy
market dynamics. The report also reviews theUnderstand what the new growth opportunities
competitive landscape in terms of mergers andare within the France diabetes care devices
acquisitions, pipeline products and technologymarket.
offerings.Develop a clear knowledge & understanding
Scopeof the France diabetes care devices competitor
Forecasts & Analysis of the France diabeteslandscape and how this will change to 2015.
care devices market to 2015.Identify acquisition opportunities across the France
Market segmentation by glucose monitoring anddiabetes care devices market.
insulin delivery. Glucose monitoring furtherIdentify key winners and losers and who is best
segmented into blood glucose meters and bloodpositioned to take advantage of the emerging
glucose test strips. Insulin delivery furthermarket opportunities.
segmented into insulin pens, insulin pumps, insulinExploit in-licensing and out-licensing opportunities by
syringes and traditional insulin pump accessories.identifying products, most likely to ensure a
Market Analysis from 2001 to 2008, including newrobust return.